# Biomedical Literature Mining Agent

**ID:** `biomedical.drug_discovery.literature_mining`
**Version:** 1.0.0
**Status:** Production
**Category:** Drug Discovery / Knowledge Extraction

---

## Overview

The **Biomedical Literature Mining Agent** extracts drug-disease relationships, drug-target interactions, and mechanistic insights from biomedical literature using transformer-based NLP models. Integration of BioBERT, DrugBERT, and large language models enables automatic identification of repurposing opportunities from text.

---

## Key Capabilities

### 1. Extraction Tasks

| Task | Description | Model |
|------|-------------|-------|
| **NER** | Named entity recognition | BioBERT |
| **RE** | Relation extraction | DrugBERT |
| **Event extraction** | Complex relationships | LLM |
| **Hypothesis generation** | Novel connections | RAG + LLM |

### 2. Entity Types

| Entity | Examples |
|--------|----------|
| **Drug** | Metformin, aspirin |
| **Disease** | Cancer, diabetes |
| **Gene/Protein** | EGFR, p53 |
| **Pathway** | mTOR, autophagy |
| **Mechanism** | Inhibition, activation |

### 3. Data Sources

- **PubMed:** 35M+ abstracts
- **PMC:** Full-text articles
- **Clinical trials:** ClinicalTrials.gov
- **Preprints:** bioRxiv, medRxiv

---

## Usage

### Example Prompt

```text
Mine literature for evidence supporting metformin repurposing
in cancer treatment.

Extract:
1. Cancer types with metformin evidence
2. Proposed mechanisms of action
3. Clinical trial results
4. Strength of evidence
```

### Expected Output

```
## Literature Mining Report: Metformin in Cancer

### Search Summary
- **Query:** Metformin AND cancer
- **Articles analyzed:** 3,847
- **Relevant extractions:** 1,245

### Cancer Types with Evidence

| Cancer Type | Articles | Clinical Trials | Evidence Level |
|-------------|----------|-----------------|----------------|
| **Breast** | 456 | 12 | Strong |
| **Colorectal** | 312 | 8 | Moderate |
| **Prostate** | 287 | 6 | Moderate |
| **Pancreatic** | 198 | 5 | Moderate |
| **Lung** | 176 | 4 | Limited |

### Extracted Mechanisms

| Mechanism | Frequency | Key References |
|-----------|-----------|----------------|
| AMPK activation | 423 | PMID:23456789 |
| mTOR inhibition | 356 | PMID:24567890 |
| IGF-1 reduction | 245 | PMID:25678901 |
| Immune modulation | 123 | PMID:26789012 |
| Gut microbiome | 67 | PMID:27890123 |

### Clinical Trial Outcomes

| Trial | Cancer | N | Result | PMID |
|-------|--------|---|--------|------|
| MA.32 | Breast | 3,649 | No benefit | 31842232 |
| NCIC | Breast | 2,533 | HR 0.81 | 29959961 |
| TAXOMET | Lung | 120 | No benefit | 28954799 |

### Evidence Summary
**Overall strength:** Moderate (epidemiological support, mixed RCT results)
**Recommendation:** Further trials in biomarker-selected populations
```

---

## References

- **Lee et al. (2020):** "BioBERT: a pre-trained biomedical language representation model." *Bioinformatics*
- **Wei et al. (2019):** "PubTator Central: automated concept annotation for biomedical full text articles."

---

## Author

**MD BABU MIA**
*Artificial Intelligence Group*
*Icahn School of Medicine at Mount Sinai*
md.babu.mia@mssm.edu
